These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Remimazolam: its clinical pharmacology and evolving role in anesthesia and sedation practice. Masui K. Curr Opin Anaesthesiol; 2024 Aug 01; 37(4):344-351. PubMed ID: 38841907 [Abstract] [Full Text] [Related]
3. Remimazolam versus propofol for endoscopy sedation in elderly patients: a systematic review, meta-analysis and trial sequential analysis. Terres MT, Assis ML, DA Silveira CB, Amaral S. Minerva Anestesiol; 2024 Sep 01; 90(9):775-784. PubMed ID: 38775443 [Abstract] [Full Text] [Related]
4. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent. Kim SH, Fechner J. Korean J Anesthesiol; 2022 Aug 01; 75(4):307-315. PubMed ID: 35585830 [Abstract] [Full Text] [Related]
10. Impact of concurrent remifentanil on the sedative effects of remimazolam, midazolam and propofol in cynomolgus monkeys. Kops MS, Pesic M, Petersen KU, Schmalix WA, Stöhr T. Eur J Pharmacol; 2021 Jan 05; 890():173639. PubMed ID: 33065095 [Abstract] [Full Text] [Related]
14. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote. Chen X, Sang N, Song K, Zhong W, Wang H, Jiang J, Huang Y, Hu P. Clin Ther; 2020 Apr 05; 42(4):614-624. PubMed ID: 32178858 [Abstract] [Full Text] [Related]